pDONR223-EPHA2 Citations (5)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal

---

Articles Citing pDONR223-EPHA2

Articles
EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis. Subbarayal P, Karunakaran K, Winkler AC, Rother M, Gonzalez E, Meyer TF, Rudel T. PLoS Pathog. 2015 Apr 23;11(4):e1004846. doi: 10.1371/journal.ppat.1004846. eCollection 2015 Apr. PubMed
Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells. Zhou Z, Li M, Zhang L, Zhao H, Sahin O, Chen J, Zhao JJ, Songyang Z, Yu D. Cancer Res. 2018 May 1;78(9):2248-2261. doi: 10.1158/0008-5472.CAN-17-2726. Epub 2018 Feb 12. PubMed
EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity. Kaibori Y, Saito Y, Nakayama Y. FASEB J. 2019 Apr;33(4):5334-5349. doi: 10.1096/fj.201801519RR. Epub 2019 Jan 22. PubMed
Localized Intercellular Transfer of Ephrin-As by Trans-endocytosis Enables Long-Term Signaling. Valenzuela JI, Perez F. Dev Cell. 2020 Jan 6;52(1):104-117.e5. doi: 10.1016/j.devcel.2019.11.013. Epub 2019 Dec 19. PubMed
Kinase activity-independent role of EphA2 in the regulation of M-phase progression. Kaibori Y, Katayama K, Tanaka Y, Ikeuchi M, Ogawa M, Ikeda Y, Yuki R, Saito Y, Nakayama Y. Exp Cell Res. 2020 Oct 15;395(2):112207. doi: 10.1016/j.yexcr.2020.112207. Epub 2020 Aug 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.